SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

IOL Chemicals soars on getting Certificate of Suitability from EDQM

25 Feb 2026 Evaluate

IOL Chemicals and Pharmaceuticals is currently trading at Rs. 74.50, up by 2.57 points or 3.57% from its previous closing of Rs. 71.93 on the BSE.

The scrip opened at Rs. 73.85 and has touched a high and low of Rs. 75.35 and Rs. 73.28 respectively. So far 40481 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 126.60 on 19-Sep-2025 and a 52 week low of Rs. 57.51 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 75.88 and Rs. 71.21 respectively. The current market cap of the company is Rs. 2186.78 crore.

The promoters holding in the company stood at 52.62%, while Institutions and Non-Institutions held 2.10% and 45.28% respectively.

IOL Chemicals and Pharmaceuticals has secured Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & Health Care (EDQM) for its API product ‘CLOPIDOGREL BESILATE’ on February 23, 2026. The company has an existing valid CEP for ‘CLOPIDOGREL BISULPHATE.’ Clopidogrel is an antiplatelet medication used in the treatment and prevention of cardiovascular diseases.

IOL Chemicals and Pharmaceuticals is India's one of the leading generic pharmaceutical companies, and is significant player in the Organic chemicals space.

IOL Chem & Pharma Share Price

91.16 5.66 (6.62%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×